EPLAW – YOUNG EPLAW 2022 Annual Congress

Posted: April 26th, 2022

After a three year covid-related hiatus, the Young EPLAW event finally took place in person again in Brussels yesterday. The event was preceded by a mock trial and a social event on Sunday. The program was busy and varied, with topics ranging from ‘Hot topics in FRAND litigation’ to ‘Confidentiality in court proceedings’ ,  ‘Cross […]


EPLAW – Webinar: Overview of the New System

Posted: March 25th, 2022

On Wednesday 23 March 2022 EPLAW held a second webinar in its webinar series dedicated to the UPC. This webinar, entitled: “Overview of the new system” gave the most recent update on timing and progress, an overview of the various sources of law, and a synopsis of the structure and possible actions, processes & timelines […]


EPLAW – Young EPLAW: save the date

Posted: February 10th, 2022

Save the date! The next Young EPLAW Congress will be held live in Brussels on 25 April 2022  There will be an informal evening reception on 24 April The Young EPLAW Event is for lawyer associates of current EPLAW members, who are on track to become members of EPLAW in the future. We ask EPLAW […]


EPLAW – Webinar: Preparations for the UPC

Posted: February 10th, 2022

Yesterday’s EPLAW webinar discussed the preparations for the UPC. Various speakers provided an overview of the events of the provisional application period, opting out, filing strategies and license agreements. Speakers were: Jako Eleveld (Philips, NL) John Meidahl (Lundbeck, DK) Amandine Métier (Hoyng ROKH Monegier, FR) Kevin Mooney (Simmons & Simmons, UK) Sture Rygaard (Plesner, DK) […]


EPLAW – Annual Congress and General Assembly 2021

Posted: November 29th, 2021

Friday 26 November, the 2021 edition of EPLAW’s Annual Congress and General Assembly 2021 was held in Brussels. Due to the continuing pandemic, it was a hybrid event, with speakers and participants attending both in person and virtually.  The event was preceeded by a social event on Thursday. The entire programme consisted of: 20 years […]


EPLAW – Webinar: Proportionality

Posted: October 15th, 2021

Yesterday’s EPLAW webinar discussed the topic of proportionality and final injunctions, it was entitled: Proportionality why not… but are there true alternatives to a final injunction? The session was moderated by Sabine Agé (Hoyng ROKH Monegier, FR). Panellistst were: Domien Op de Beeck – Bird&Bird, BE Ida Gjessing – Gjessing Reimers, NO Ari Laakkonen – […]


EPLAW – Webinar – Covid-19: Vaccines and Patents – a European Perspective

Posted: June 14th, 2021

On 11 June 2021 EPLAW hosted a succesful webinar for its members on the hot topic of Covid-19 vaccines and patents. After an introduction by Klaus Haft (Hoyng ROKH Monegier, DE), various speakers discussed the topic from different angles. Key question was whether a patent waiver and/or compulsory license will be the solution to the […]


UPC – EPLAW asks UPC Preparatory Commitee to consider parties’ wishes for remote hearings

Posted: June 1st, 2021

EPLAW has written to the UPC Preparatory Committee noting that while the benefits of remote hearings have been much appreciated in national proceedings during the current health crisis, in more normal times fully remote trials should not become a new normal and certainly should not be imposed upon parties’ against their express wish. The Committee […]


EPLAW – YOUNG EPLAW Mock Trial and Congress 2021

Posted: April 20th, 2021

EPLAW hosted the virtual Young EPLAW Mock Trial and Congress on 18 and 19 April. Young EPLAW is a yearly event open for associates of EPLAW members up to the age of 36. In recent years, the Congress is preceded by a Mock Trial. In the Mock Trial, 18 advocates pleaded a patent case concerning […]


EPLAW – Knowledge seminar – Bayer vs Richter: A support for innovation or a set back for justice?

Posted: February 19th, 2021

Yesterday, EPLAW hosted the third session of its succesful knowledge webinars series. In this webinar an international panel of practitioners moderated by Willem Hoyng (HOYNG ROKH MONEGIER) discussed CJEU’s controversial Bayer (CJEU C-688/17) judgment and its potential impact on patent litigation in Europe. In particular, the following questions were debated: Is Bayer vs Richter a […]